6-G1 2AB (500pmol/vial)1vial

5-Cyclopropylpyridin-2-ol, 95.0%, 5g

2-Methyldibenzo[f,h]quinoxaline>98.0%(GC)1g

(S)-2-Amino-3-(2,5-dichlorophenyl)propanoic acid, 95.0%, 10g

Ethyl 5-bromo-2-chlorobenzoate, 98.0%, 5g

5-amino-1-methylpiperidin-2-one, 95.0%, 100mg

5,6,7,8-Tetrahydro-1,6-naphthyridine hydrochloride, 95.0%, 1g

(S)-3-((tert-Butoxycarbonyl)amino)-3-(3-fluorophenyl)propanoic acid, 95.0%, 250mg

3,4-Dihydroquinazolin-2(1H)-one, 95.0%, 250mg

4-Hydroxythiophene-2-carbaldehyde, 250mg

4-Bromo-3,5-dichloropyridine, 98.0%, 10g

5-Chloro-2-methylnicotinic acid methyl ester, 95.0%, 1g

2-(4-Chloro-phenyl)-cyclopropylamine hydrochloride, 97%, 100mg